Integrated Analysis of Gene Expression, Methylation, and Gene Copy Number in Breast Cancer Cells
Author Information
Author(s): Sun Zhifu, Asmann Yan W., Kalari Krishna R., Bot Brian, Eckel-Passow Jeanette E., Baker Tiffany R., Carr Jennifer M., Khrebtukova Irina, Luo Shujun, Zhang Lu, Schroth Gary P., Perez Edith A., Thompson E. Aubrey
Primary Institution: Mayo Clinic College of Medicine
Hypothesis
How are transcriptome, gene copy number, and CpG island methylation status integrated in breast cancer?
Conclusion
The study reveals a global pattern of differential CpG island methylation that contributes to the transcriptome landscape of ER+ and ER− breast cancer cells.
Supporting Evidence
- 1,873 genes were differentially expressed in ER+ and ER− cell lines.
- 149 differentially expressed genes exhibited inverse correlation with CpG island methylation.
- Pathway analysis revealed significant enrichment of known ER-associated functions.
Takeaway
Researchers looked at how genes behave in breast cancer cells and found that some genes are turned on or off based on their DNA's chemical tags and how many copies of them are present.
Methodology
Deep sequencing technology was used to profile mRNA, gene copy number, and CpG island methylation in breast cancer cell lines.
Potential Biases
Potential bias due to the use of specific cell lines that may not capture the full diversity of breast cancer.
Limitations
The study primarily focuses on cell lines, which may not fully represent primary tumors.
Participant Demographics
The study involved 8 breast cancer cell lines, including 4 ER+ and 3 ER−.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: -0.81 to -0.68
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website